Abstract
Interspecies variation in pharmacokinetics is considered and treated as a property and consequence of body size (allometry). Consequently, it is possible to reference (scale) pharmacokinetic parameters to the organism's individual anatomy, biochemistry, and/or physiology in such a manner that differences between species are nullified. Thus, in the mouse, rat, dog, monkey, and human, methotrexate plasma clearance always equals 133% of creatinine clearance and as such becomes invariant. Pharmacokinetic time (a variable in terms of chronological time) is shown to be a form of physiological time in which a pharmacokinetic event becomes the independent variable, e.g., disposition halflife. A relationship between pharmacokinetic time and body size is demonstrated. It is suggested that man's lesser quantitative ability to metabolize many drugs may be correlated with his enhanced longevity.
References
H. Boxenbaum. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.J. Pharmacokin. Biopharm. 8:165–176 (1980).
A. Carrel. Physiological time.Science 74:618–621 (1931).
S. Brody. Relativity of physiologic time and physiologic weight.Growth 1:60–67 (1937).
S. J. Gould. One standard lifespan.New Scientist 81:388–389 (1979).
S. J. Gould. Allometry and size in ontogeny and phylogeny.Biol. Rev. 41:587–640 (1966).
W. R. Stahl. The analysis of biological similarity.Adv. Biol. Med. Phys.,9:355–464 (1963).
B. Günther and B. León de la Barra. On the space-time continuum in biology.Acta Physiol. Latinamerica 16:221–231 (1966).
L. K. Frank. Structure, function and growth.Phil. Sci. 2:210–235 (1935).
R. L. Dedrick, K. B. Bischoff, and D. Z. Zaharko. Interspecies correlation of plasma concentration history of methotrexate (NSC-740).Cancer Chemother. Rep., Part I54:95–101 (1970).
E. F. Adolph. Quantitative relations in the physiological constitutions of mammals.Science 109:579–585 (1949).
J. P. Holt and E. A. Rhode. Similarity of renal glomerular hemodynamics in mammals.Am. Heart. J. 92:465–472 (1976).
W. L. Stahl. Physiological design criteria.Proc. 17th Ann. Conf. Eng. in Med. Biol., 1964, p. 60.
W. A. Calder III. Scaling of physiological processes in homeothermic animals.Ann. Rev. Physiol. 43:301–322 (1981).
N. A. Edwards. Scaling of renal function in mammals.Comp. Biochem. Physiol. 52A:63–66 (1975).
E. S. Henderson, R. H. Adamson, C. Denham and V. T. Oliverio. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.Cancer Res. 25:1008–1017 (1965).
K. Schmidt-Nielsen. Scaling in biology: the consequences of size.J. Exp. Zool. 194:297–308 (1975).
G. Galilei.Dialogues concerning two new sciences, 1637, translated by H. Crew and A. De Salvio, Macmillan, New York, 1914.
E. F. Adolph.Physiological Regulations, The Jaques Cattell Press, Lancaster, Pa., 1943.
L. B. Mellet. Comparative drug metabolism.Prog. Drug. Res. 13:136–169 (1969).
G. T. Okita. Species difference in duration of action of cardiac glycosides.Fed. Proc. 26:1125–1130 (1967).
G. P. Quinn, J. Axelrod, and B. B. Brodle. Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and aniline.Biochem. Pharmacol. 1:152–159 (1958).
J. J. Burns. Species differences and individual variations in drug metabolism. In B. B. Brodie and E. G. Erdös (Eds.),Proc. 1st International Pharmacological Meeting, Vol. 6, Pergamon Press, New York, 1962, pp. 277–287.
B. M. Boulos, W. L. Jenkins, and L. Davis. Pharmacokinetics of certain drugs in the domesticated goat.Am. J. Vet. Res. 33:943–952 (1972).
H. G. Boxenbaum. Comparative pharmacokinetics of benzodiazepines in dog and man.J. Pharmacokin. Biopharm., submitted for publication.
B. Günther. Physiological time and its evolution. In A. Locker (Ed.),Biogenesis Evolution Homeostasis, Springer-Verlag, Heidelberg, 1973, pp. 127–133.
M. Kleiber. Metabolic turnover rate: a physiological meaning of the metabolic rate per unit body weight.J. Theor. Biol. 53:199–204 (1975).
A. M. Hemmingsen. Energy metabolism as related to body size and respiratory surface and its evolution.Rep. Sten. Meml. Hosp. Nord. Insulin Lab. 9:1–110 (1960).
J. W. Prothero. Maximal oxygen consumption in various animals and plants.Comp. Biochem. Physiol. 64A:463–466 (1979).
B. Günther and E. Guerra. Theory of biological similarity applied to some data of comparative physiology.Acta Physiol. Latinamerica 7:95–103 (1957).
W. L. Beeken, W. Volwiler, P. D. Goldsworthy, L. E. Garby, W. E. Reynolds, R. Stogsdill, and R. S. Stemler. Studies of I131-albumin catabolism and distribution in normal young male adults.J. Clin. Invest. 41:1312–1333 (1962).
H. N. Munro and E. D. Downie. Relationship of liver composition to intensity of protein metabolism in different mammals.Nature 203:603–604 (1964).
W. S. Spector (Ed.).Handbook of Biological Data, W. B. Saunders, Philadelphia, 1956, pp. 163–164, 339.
N. I. Berlin, T. A. Waldmann, and S. M. Weissman. Life span of red blood cell.Physiol. Rev. 39:577–616 (1959).
P. L. Altman and D. S. Dittmer (Eds.),Biology Data Book, 2nd ed., Vol I, Federation of American Societies for Experimental Biology, Bethesda, Md., 1972, pp. 100,416–422.
O. L. Reiser.Philosphy and the Concepts of Modern Science. Macmillan, New York, 1935, pp. 43–78, 239–263.
D. S. Riggs.The Mathematical Approach to Physiological Problems. Williams and Wilkins, Baltimore, 1963, pp. 295–296.
G. R. Wilkinson and D. G. Shand. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
R. G. Cutler. Evolution of longevity in primates.J. Hum. Evol. 5:169–202 (1976).
W. D. Donckla. A time to die.Life Sci. 16:31–44 (1975).
R. G. Cutler. Evolution of human longevity: a critical overview.Mech. Ageing Dev. 9:337–354 (1979).
S. Seely. The evolution of human longevity.Med. Hypotheses 6:873–882 (1980).
G. A. Sacher. Relationship of lifespan to brain weight and body weight in mammals.Ciba Found. Colloq. Aging 5:115–133 (1959).
D. L. Drabkin. Imperfection: biochemical phobias and metabolic ambivalence.Persp. Biol. Med. 2:473–517 (1959).
J. B. S. Haldane. The theory of the evolution of dominance.J. Genet. 37:365–374 (1939).
P. M. Sheppard.Natural Selection and Heredity, Harper & Row, New York, 1960, pp. 129–145.
J. B. Harborne.Introduction to Ecological Biochemistry, Academic Press, New York, 1977, p. 143.
J. Alberola and L. J. Izquierdo. The volatile fraction of orange juice. Methods for extraction and study of composition. In G. Charalambous and G. E. Inglett (Eds.),Flavor of Foods and Beverages: Chemistry and Technology, Academic Press, New York 1978, pp. 283–304.
K. S. Pang. Hepatic clearances of drugs and metabolites.Trends Pharmacol. Sci. (June 1980), pp. 247–251.
D. G. Shand, D. M. Kornhauser, and G. R. Wilkinson. Effects of rate of administration and blood flow on hepatic drug elimination.J. Pharmacol. Exp. Ther. 195:424–432 (1975).
M. Rowland, T. R. Blaschke, P. J. Meffin, and R. L. Williams. Pharmacokinetics in disease states modifying hepatic and metabolic function. In L. Z. Benet (Ed.),The Effect of Disease States on Drug Pharmacokinetics, Am. Pharm. Assoc. Acad. Pharm. Sci., Washing-ton, D.C., 1976, Chap. 4, pp. 53–75.
G. A. Sacher. Maturation and longevity in relation to cranial capacity in hominid evolution. In R. H. Tuttle (Ed.),Primate Functional Morphology and Evolution, Mouton, The Hague, 1975, pp. 417–441.
S. Brody.Bioenergetics and Growth, Hafner, New York, 1964, p. 592.
O. Kestner. Metabolism and size of organs.J. Physiol. 87:39P-41P (1936).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boxenbaum, H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 10, 201–227 (1982). https://doi.org/10.1007/BF01062336
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062336